Breaking News: The FDA plans to allow immunocompromised Americans to receive a third dose of Pfizer or Modenacovid vaccine tomorrow
- The FDA plans to allow Americans with a weakened immune system to receive a third COVID-19 vaccine. Thursday
- Past studies have shown that people with a weakened immune system, even after being completely vaccinated, have low or undetectable antibody levels.
- Both Pfizer and Modana have been conducting booster shot clinical trials since the winter of 2021
The US Food and Drug Administration (FDA) plans to allow Americans with a weakened immune system to receive a third COVID-19 vaccination starting tomorrow.
Sources tell NBC News that the Federal Health Organization will expand Emergency use authorization for Pfizer-BioNTech and Moderna vaccines will allow them to be administered as booster shots.
3% of all Americans are considered immunodeficient due to cancer treatment, autoimmune disease, HIV, or other illnesses.
Over the past few months, some studies have suggested that immunocompromised people do not have as much protection after being fully vaccinated as healthy people.
The FDA plans to allow Americans with a weakened immune system to receive a third COVID-19 vaccination on Thursday.Photo: April 7, Moderna COVID-19 vaccine vial
Earlier, health experts said there was no evidence to suggest that fully vaccinated Americans needed booster shots.
However, more and more studies show that people with a weakened immune system have low or undetectable antibody levels even after two doses.
A May study found that all cancer patients developed fewer antibodies after vaccination compared to healthy participants, with 10% developing very little antibody.
Another June study examined 30 organ transplant recipients and found that after two doses of Pfizer-BioNTech or Moderna vaccine, 24 showed negative antibody levels.
The findings are worrisome because people with immunodeficiency are already at high risk of hospitalization and death from the virus.
This makes COVID-19 immunity even more important for this population.
However, a third dose may be a way to increase antibody levels.
For example, a study of organ transplant patients found that one-third of patients who had negative antibody levels on the first two doses showed an increase after the third dose.
The largest increase seen was antibody levels that increased 687-fold.
Last month, the CDC’s Immunization Implementation Advisory Board said authorities were working to make additional doses available to people with immunodeficiency.
“I think you’re looking for a way to provide an individual with a third dose, as you know … through research or through a new drug format under investigation for this population?” Amanda Corn, chief medical officer of the CDC’s vaccine policy, told the panel.
“I’m just saying that we are actively looking at what we can do to provide access faster than potential changes in regulatory decisions.”
ACIP cannot recommend a third dose until the FDA fully approves the vaccine or expands emergency use to include boosters.
However, ACIP has a meeting on Friday and may vote on whether to recommend boosters.
At a press conference last week, Dr. Anthony Fauci said that people with weakened immunity are “vulnerable” to COVID-19 infection, and the Biden administration gives Americans with immunodeficiency a COVID-19 vaccine booster shot. He said he is working to approve.
They generally do not respond appropriately [to the COVID-19 vaccine] We feel that we can protect it well. “
“It’s very important that we move to give those individuals a booster, and we’re currently working on it, and for us, and for the individuals involved, it’s a very high priority, so We will implement it as soon as possible. ”
This is the latest news and will be updated.
The FDA will allow immunocompromised Americans to receive a third dose of the Covid vaccine tomorrow.
Source link The FDA will allow immunocompromised Americans to receive a third dose of the Covid vaccine tomorrow.